These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 23447688)
1. Shear stress-dependent downregulation of the adhesion-G protein-coupled receptor CD97 on circulating leukocytes upon contact with its ligand CD55. Karpus ON; Veninga H; Hoek RM; Flierman D; van Buul JD; Vandenakker CC; vanBavel E; Medof ME; van Lier RA; Reedquist KA; Hamann J J Immunol; 2013 Apr; 190(7):3740-8. PubMed ID: 23447688 [TBL] [Abstract][Full Text] [Related]
2. Deletion of either CD55 or CD97 ameliorates arthritis in mouse models. Hoek RM; de Launay D; Kop EN; Yilmaz-Elis AS; Lin F; Reedquist KA; Verbeek JS; Medof ME; Tak PP; Hamann J Arthritis Rheum; 2010 Apr; 62(4):1036-42. PubMed ID: 20131275 [TBL] [Abstract][Full Text] [Related]
3. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). Hamann J; Vogel B; van Schijndel GM; van Lier RA J Exp Med; 1996 Sep; 184(3):1185-9. PubMed ID: 9064337 [TBL] [Abstract][Full Text] [Related]
4. Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis. Visser L; de Vos AF; Hamann J; Melief MJ; van Meurs M; van Lier RA; Laman JD; Hintzen RQ J Neuroimmunol; 2002 Nov; 132(1-2):156-63. PubMed ID: 12417446 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Hamann J; Stortelers C; Kiss-Toth E; Vogel B; Eichler W; van Lier RA Eur J Immunol; 1998 May; 28(5):1701-7. PubMed ID: 9603477 [TBL] [Abstract][Full Text] [Related]
6. CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells. van Pel M; Hagoort H; Hamann J; Fibbe WE Haematologica; 2008 Aug; 93(8):1137-44. PubMed ID: 18603564 [TBL] [Abstract][Full Text] [Related]
7. CD97 antibody depletes granulocytes in mice under conditions of acute inflammation via a Fc receptor-dependent mechanism. Veninga H; de Groot DM; McCloskey N; Owens BM; Dessing MC; Verbeek JS; Nourshargh S; van Eenennaam H; Boots AM; Hamann J J Leukoc Biol; 2011 Mar; 89(3):413-21. PubMed ID: 21169517 [TBL] [Abstract][Full Text] [Related]
9. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay-accelerating factor (DAF, CD55). Qian YM; Haino M; Kelly K; Song WC Immunology; 1999 Oct; 98(2):303-11. PubMed ID: 10540231 [TBL] [Abstract][Full Text] [Related]
10. Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells. Kwakkenbos MJ; Pouwels W; Matmati M; Stacey M; Lin HH; Gordon S; van Lier RA; Hamann J J Leukoc Biol; 2005 Jan; 77(1):112-9. PubMed ID: 15498814 [TBL] [Abstract][Full Text] [Related]
12. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55. Abbott RJ; Spendlove I; Roversi P; Fitzgibbon H; Knott V; Teriete P; McDonnell JM; Handford PA; Lea SM J Biol Chem; 2007 Jul; 282(30):22023-32. PubMed ID: 17449467 [TBL] [Abstract][Full Text] [Related]
13. Expression of CD97 and CD55 in human medullary thyroid carcinomas. Mustafa T; Klonisch T; Hombach-Klonisch S; Kehlen A; Schmutzler C; Koehrle J; Gimm O; Dralle H; Hoang-Vu C Int J Oncol; 2004 Feb; 24(2):285-94. PubMed ID: 14719104 [TBL] [Abstract][Full Text] [Related]
14. CD97-decay-accelerating factor interaction is not involved in leukocyte adhesion to endothelial cells. Boulday G; Hamann J; Soulillou JP; Charreau B Transplantation; 2002 Feb; 73(3):429-36. PubMed ID: 11884941 [TBL] [Abstract][Full Text] [Related]
15. Structural basis for CD97 recognition of the decay-accelerating factor CD55 suggests mechanosensitive activation of adhesion GPCRs. Niu M; Xu S; Yang J; Yao D; Li N; Yan J; Zhong G; Song G J Biol Chem; 2021; 296():100776. PubMed ID: 33992645 [TBL] [Abstract][Full Text] [Related]
16. N-glycosylation of CD97 within the EGF domains is crucial for epitope accessibility in normal and malignant cells as well as CD55 ligand binding. Wobus M; Vogel B; Schmücking E; Hamann J; Aust G Int J Cancer; 2004 Dec; 112(5):815-22. PubMed ID: 15386373 [TBL] [Abstract][Full Text] [Related]
17. CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model. Ward Y; Lake R; Martin PL; Killian K; Salerno P; Wang T; Meltzer P; Merino M; Cheng SY; Santoro M; Garcia-Rostan G; Kelly K Oncogene; 2013 May; 32(22):2726-38. PubMed ID: 22797060 [TBL] [Abstract][Full Text] [Related]
18. CD97 promotes spleen dendritic cell homeostasis through the mechanosensing of red blood cells. Liu D; Duan L; Rodda LB; Lu E; Xu Y; An J; Qiu L; Liu F; Looney MR; Yang Z; Allen CDC; Li Z; Marson A; Cyster JG Science; 2022 Feb; 375(6581):eabi5965. PubMed ID: 35143305 [TBL] [Abstract][Full Text] [Related]
19. The role of ADGRE5/CD97 in human retinal pigment epithelial cell growth and survival. Eichler W; Lohrenz A; Simon KU; Krohn S; Lange J; Bürger S; Liebscher I Ann N Y Acad Sci; 2019 Nov; 1456(1):64-79. PubMed ID: 31397926 [TBL] [Abstract][Full Text] [Related]
20. Role of CD97(stalk) and CD55 as molecular markers for prognosis and therapy of gastric carcinoma patients. Liu Y; Chen L; Peng SY; Chen ZX; Hoang-Vu C J Zhejiang Univ Sci B; 2005 Sep; 6(9):913-8. PubMed ID: 16130195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]